Growth hormone is one of 618 small molecule programs targeting Insulin resistance. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1931 competitors in COVID-19
Growth hormone
Spikevax
Bnt162b2
COVID-19 Vaccine
Biaxin
Aimovig
Aldactone
Nexavar
Singulair
Stivarga
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources